Biorbyt News

Royal representative presents Biorbyt with Queen's Award

Biorbyt is proud to have been presented a Queen’s Award for Enterprise in International Trade during a visit from Mrs Julie Spence, OBE, QPM, Her Majesty’s Lord-Lieutenant of Cambridgeshire. Accompanied by Deputy Lieutenant Penelope Walkinshaw, and Sgt Maj Rhyder Cameron-Wickes, Lord-Lieutenant’s Cadet, this celebration started with the distinguished guests enjoying a tour of the company’s premises and learning about Biorbyt’s history and its role in life sciences research. This was followed by speeches from the Lord-Lieutenant and Deputy Lieutenant, and the presentation of the prestigious crystal Queen’s Award trophy. After the ceremony, the royal representatives met members of the Biorbyt team while enjoying refreshments.Find out more

15th December 2021

Jack Cooper: Ditching the lab coat to help others

KDM Communications chat with Jack Cooper, who has emerged from the lab to establish himself as a product manager at Biorbyt, combining his wealth of scientific knowledge with his interpersonal skills to benefit customers. Read the article

24th September 2021

Biorbyt are Queen's Award for Enterprise Winners 2021

We are immensely proud recipients of the Queen's Award for Enterprise: International Trade. This is a tremendous accolade and testament to all the hard work our team has done over the last decade. What an incredible way to celebrate our 10th year anniversary!

29th April 2021

Celebrating our 10^th Year Anniversary

2021 is a very special year for Biorbyt as we celebrate our tenth year. As a company, we are proud to serve a satisfied customer base. As an employer, we are excited to create a global business that supports, challenges, and nurtures talent. As a small business, we are part of a network of companies that support each other.

10th January 2021

Qun Yang sharing her experience and research

Qun Yang, co-founder of Biorbyt, and Christopher R. Lowe, from the University of Cambridge, talk about antibody testing and how the scientific community has risen to the challenge posed by Covid-19. Watch it here

1st September 2020

Siân Bolitho providing scientific insight

Siân Bolitho, Commercial Manager at Biorbyt, recently interviewed by Biocompare giving expert advice on optimizing immunoassay design and validation. Read more

24th August 2020

Biorbyt donates to Addenbrooke's

Biorbyt has recently donated 50 goggles and 50 coverall suits to Addenbrooke's Hospital.

14th July 2020

Qun Yang talking with ICAEW

Read how Qun Yang, co-founder of Biorbyt, is accelerating the company's adapting action to overcome the challenges COVID-19 has presented. Read more

21st May 2020

Biorbyt on CGTN FRANÇAIS

A French news report on the importance of communication between Europe and China in the fight against CoVid-19. Biorbyt and other Cambridge start-ups are at the front line in helping the research on Coronavirus. Cambridge is world-renowned for its scientific excellence and Biorbyt are collaborating with Crayfish.io who offer a translating platform to facilitate the collaboration between China and the UK. This helps Biorbyt's provision of antibodies to research institutes around the world.

Qun Yang, co-founder of Biorbyt, says:

"The only way to get out of this crisis is by doing research in order to gain a better understanding of the virus."

1st May 2020

Coronavirus Research Products

We have a useful array of products to help with your Coronavirus research.

Our range include primary antibodies and antigens, Small Molecules, ELISA Kits and Proteins for:

Biorbyt on BBC Look East

Commercial Manager Siân Bolitho discusses Biorbyt's role in supplying antibodies for the Coronavirus outbreak. Ting Zhang from Crayfish discusses how her translation software enables a more efficient workflow for Biorbyt.

Siân says:

"We’ve started by using antibodies to very closely-related viruses...the SARS and the MERS from previous outbreaks...and we’ve looked at the sequences that were very quickly generated by Chinese scientists who sequenced the virus themselves, and they’re developing assays, they’re researching into how the virus mutates, how the virus is transmitted, and they’re looking to find a cure."